https://www.ft.com/content/f2c980f1-2311-49da-ad01-dada2b56fc90
Gamida Cell Announces Launch of Public Offering of Ordinary Shares, Size Not Disclosed
Gamida Cell Ltd. (NASDAQ:GMDA), the global leader in the development of NAM-enabled cell therapies for patients with hematologic and solid cancers and other serious diseases, today announced the launch of a follow-on